Yongdong Zhao1, Eveline Y Wu2, Melissa S Oliver3, Ashley M Cooper4, Matthew L Basiaga1, Sheetal S Vora5, Tzielan C Lee3, Emily Fox4, Gil Amarilyo6, Sara M Stern7, Jeffrey A Dvergsten8, Kathleen A Haines9, Kelly A Rouster-Stevens10, Karen B Onel11, Julie Cherian12, Jonathan S Hausmann13, Paivi Miettunen14, Tania Cellucci15, Farzana Nuruzzaman12, Angela Taneja10, Karyl S Barron16, Matthew C Hollander17, Sivia K Lapidus18, Suzanne C Li9, Seza Ozen19, Hermann Girschick20, Ronald M Laxer21, Fatma Dedeoglu22, Christian M Hedrich23, Polly J Ferguson24. 1. Seattle Children's Hospital, University of Washington, Seattle. 2. University of North Carolina, Chapel Hill. 3. Stanford Children's Health, Stanford University, Palo Alto, California. 4. Children's Mercy, Kansas City, Missouri. 5. Levine Children's Hospital, Charlotte, North Carolina. 6. Schneider Children's Medical Center of Israel, Petach Tikva Israel, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 7. University of Utah, Salt Lake City. 8. Duke Children's Hospital, Durham, North Carolina. 9. Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, New Jersey. 10. Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia. 11. Hospital for Special Surgery, New York, New York. 12. Stony Brook Children's Hospital, Stony Brook, New York. 13. Boston Children's Hospital and Beth Israel Deaconess Medical Center, Boston, Massachusetts. 14. University of Calgary, Calgary, Alberta, Canada. 15. McMaster Children's Hospital, Hamilton, Ontario, Canada. 16. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. 17. University of Vermont Medical Center, Burlington. 18. Goryeb Children's Hospital, Morristown, New Jersey. 19. Hacettepe University, Ankara, Turkey. 20. Vivantes Children's Hospital in Friedrichshain, Berlin, Germany. 21. The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada. 22. Boston Children's Hospital, Boston, Massachusetts. 23. Children's Hospital Dresden, University Medical Center Carl Gustav Carus, TU Dresden, Dresden, Germany, and Institute of Translational Medicine, University of Liverpool, and Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK. 24. University of Iowa Carver College of Medicine, Iowa City.
Abstract
OBJECTIVE: To develop standardized treatment regimens for chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO), to enable comparative effectiveness treatment studies. METHODS: Virtual and face-to-face discussions and meetings were held within the CNO/CRMO subgroup of the Childhood Arthritis and Rheumatology Research Alliance (CARRA). A literature search was conducted, and CARRA membership was surveyed to evaluate available treatment data and identify current treatment practices. Nominal group technique was used to achieve consensus on treatment plans for CNO refractory to nonsteroidal antiinflammatory drug (NSAID) monotherapy and/or with active spinal lesions. RESULTS: Three consensus treatment plans (CTPs) were developed for the first 12 months of therapy for CNO patients refractory to NSAID monotherapy and/or with active spinal lesions. The 3 CTPs are methotrexate or sulfasalazine, tumor necrosis factor inhibitors with optional methotrexate, and bisphosphonates. Short courses of glucocorticoids and continuation of NSAIDs are permitted for all regimens. Consensus was achieved on these CTPs among CARRA members. Consensus was also reached on subject eligibility criteria, initial evaluations that should be conducted prior to the initiation of CTPs, and data items to collect to assess treatment response. CONCLUSION: Three consensus treatment plans were developed for pediatric patients with CNO refractory to NSAIDs and/or with active spinal lesions. Use of these CTPs will provide additional information on efficacy and will generate meaningful data for comparative effectiveness research in CNO.
OBJECTIVE: To develop standardized treatment regimens for chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO), to enable comparative effectiveness treatment studies. METHODS: Virtual and face-to-face discussions and meetings were held within the CNO/CRMO subgroup of the Childhood Arthritis and Rheumatology Research Alliance (CARRA). A literature search was conducted, and CARRA membership was surveyed to evaluate available treatment data and identify current treatment practices. Nominal group technique was used to achieve consensus on treatment plans for CNO refractory to nonsteroidal antiinflammatory drug (NSAID) monotherapy and/or with active spinal lesions. RESULTS: Three consensus treatment plans (CTPs) were developed for the first 12 months of therapy for CNO patients refractory to NSAID monotherapy and/or with active spinal lesions. The 3 CTPs are methotrexate or sulfasalazine, tumor necrosis factor inhibitors with optional methotrexate, and bisphosphonates. Short courses of glucocorticoids and continuation of NSAIDs are permitted for all regimens. Consensus was achieved on these CTPs among CARRA members. Consensus was also reached on subject eligibility criteria, initial evaluations that should be conducted prior to the initiation of CTPs, and data items to collect to assess treatment response. CONCLUSION: Three consensus treatment plans were developed for pediatric patients with CNO refractory to NSAIDs and/or with active spinal lesions. Use of these CTPs will provide additional information on efficacy and will generate meaningful data for comparative effectiveness research in CNO.
Authors: Sarah Ringold; Pamela F Weiss; Robert A Colbert; Esi Morgan DeWitt; Tzielan Lee; Karen Onel; Sampath Prahalad; Rayfel Schneider; Susan Shenoi; Richard K Vehe; Yukiko Kimura Journal: Arthritis Care Res (Hoboken) Date: 2014-07 Impact factor: 4.794
Authors: H J Girschick; P Raab; S Surbaum; A Trusen; S Kirschner; P Schneider; T Papadopoulos; H K Müller-Hermelink; P E Lipsky Journal: Ann Rheum Dis Date: 2005-02 Impact factor: 19.103
Authors: C Catalano-Pons; A Comte; J Wipff; P Quartier; A Faye; D Gendrel; A Duquesne; R Cimaz; C Job-Deslandre Journal: Rheumatology (Oxford) Date: 2008-07-11 Impact factor: 7.580
Authors: Mikhail M Kostik; Olga L Kopchak; Irina A Chikova; Eugenia A Isupova; Alexander Y Mushkin Journal: Rheumatol Int Date: 2018-08-31 Impact factor: 2.631
Authors: A V Ramanan; L V Hampson; H Lythgoe; A P Jones; B Hardwick; H Hind; B Jacobs; D Vasileiou; I Wadsworth; N Ambrose; J Davidson; P J Ferguson; T Herlin; A Kavirayani; O G Killeen; S Compeyrot-Lacassagne; R M Laxer; M Roderick; J F Swart; C M Hedrich; M W Beresford Journal: PLoS One Date: 2019-06-05 Impact factor: 3.240